Vivos Therapeutics (VVOS) Receivables - Net (2019 - 2025)
Historic Receivables - Net for Vivos Therapeutics (VVOS) over the last 7 years, with Q3 2025 value amounting to $2.1 million.
- Vivos Therapeutics' Receivables - Net rose 37004.41% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 37004.41%. This contributed to the annual value of $430000.0 for FY2024, which is 11287.13% up from last year.
- Vivos Therapeutics' Receivables - Net amounted to $2.1 million in Q3 2025, which was up 37004.41% from $1.6 million recorded in Q2 2025.
- Vivos Therapeutics' Receivables - Net's 5-year high stood at $3.8 million during Q3 2021, with a 5-year trough of $202000.0 in Q4 2023.
- Over the past 5 years, Vivos Therapeutics' median Receivables - Net value was $718000.0 (recorded in 2025), while the average stood at $1.1 million.
- In the last 5 years, Vivos Therapeutics' Receivables - Net crashed by 7740.73% in 2022 and then skyrocketed by 37004.41% in 2025.
- Quarter analysis of 5 years shows Vivos Therapeutics' Receivables - Net stood at $1.2 million in 2021, then tumbled by 62.01% to $457000.0 in 2022, then crashed by 55.8% to $202000.0 in 2023, then soared by 112.87% to $430000.0 in 2024, then skyrocketed by 396.28% to $2.1 million in 2025.
- Its Receivables - Net was $2.1 million in Q3 2025, compared to $1.6 million in Q2 2025 and $718000.0 in Q1 2025.